A caring CRO, CEO
I really liked Kevin. There is something very calm and reassuring about him. Maybe it is the North Carolina accent, but he has this lovely, likeable Southern vibe that makes you want to listen to what he has to say.
What came through most strongly was how much he still loves both the science and the business. After more than 30 years in the CRO world, you could forgive someone for becoming a little cynical or tired of it all. Kevin is the opposite. He still talks about new molecules, new technologies and the role CROs play in drug development with genuine excitement.
I also loved one particular phrase he used.
“Big enough to deliver, but small enough to care.”
It sums up so much of what smaller specialist CROs should be trying to do. And maybe smaller boutique shops elsewhere in the outsourcing space too.
You need the scale, the science and the capability to deliver for clients. But you also need the flexibility, responsiveness and personal attention that can sometimes get lost in a much bigger organisation.
And care seems to be a big part of Kevin’s leadership style generally. He talked about being someone who would “run to the flame” when there was a difficult challenge to solve. But equally, he has clearly invested a lot of thought into culture and people.
Another line that really stuck with me was the idea that people need to know that you care before they care what you know. Classy stuff.
Because for someone with Kevin’s level of experience and technical credibility, it would be very easy to lead with knowledge and expertise alone.vInstead, he seems to lead with both.
That same thinking comes through in how he talks about customers too. Lead with the science. Deliver what you said you would deliver. Communicate properly. Do not make the customer micromanage you. In other words, talk the talk and then actually walk it. Feels so tried and tested.
Having spent so much of his career inside some of the biggest CROs in the world, I also liked that he deliberately wanted to test himself in a smaller, private equity backed organisation. Not because he had anything left to prove to anyone else, but because he wanted to know that he could take everything he had learned and apply it in a different environment.That says quite a lot about him.
Calm. Experienced. Scientific. Commercial. But above all, caring. And in an outsourcing industry built on trust, relationships and delivery, that still matters a lot.
🎧 Hear the full episode here: Apple | Spotify
As always, thank you to our sponsors Bora Pharmaceuticals and Lead Candidate for supporting Molecule to Market